Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

Yves Beguin, MD PhD, Pierre Zachee, MD PhD, Johan Maertens, MD PhD, Tessa Kerre, MD PhD, Aurelie Ory, Laurence Seidel, Carlos Graux, MD PhD, Philippe Lewalle, MD PhD, Michel Van Gelder, PhD MD, Koen Theunissen, Evelyne Willems, MD PhD, Marie-Paule Emonds, Ann De Becker, Frederic Baron

Blood (2014) 124 (21): 542.

https://doi.org/10.1182/blood.V124.21.542.542

Published: 2014

Journal Articles

Long-Term Safety Follow-up of a Randomized Trial of Darbepoetin Alpha and Intravenous Iron Following Autologous Hematopoietic Cell Transplantation

Aurélie Jaspers, MD, Frederic Baron, MD PhD, Johan Maertens, MD PhD, Bernard J. M. De Prijck, MD, Henri (Rik) Schots, MDPhD, Christophe Bonnet, MD PhD, Kaoutar Hafraoui, MD, Evelyne Willems, MD PhD, Sophie Servais, MD PhD, Georges Fillet, MD PhD, Yves Beguin, MD PhD

Blood (2014) 124 (21): 3948.

https://doi.org/10.1182/blood.V124.21.3948.3948

Published: 2014

Journal Articles

Nonmyeloablative Stem Cell Transplantation with CD8-Depleted or Unmanipulated Peripheral Blood Stem Cells: A Prospective Randomized Trial.

Evelyne Willems, MD, Emilie Castermans, Frédéric Baron, MD, PhD, Etienne Baudoux, MD, Nadine Wanten, Christophe Bonnet, MD, Kaoutar Hafraoui, MD, Pascale Frère, MD, Georges Fillet, MD, PhD, Yves Beguin, MD, PhD

Blood (2005) 106 (11): 1075.

https://doi.org/10.1182/blood.V106.11.1075.1075

Published: 2005

Journal Articles

Pegfilgrastrim Compared with Filgrastim after Autologous Hematopoietic Peripheral Blood Stem Cell Transplantation.

Gaetan Vanstraelen, MD, Pascale Frère, MD, Marie-Christine Ngirabacu, MS, Evelyne Willems, MD, Georges Fillet, MD, Yves Beguin, MD

Blood (2005) 106 (11): 5287.

https://doi.org/10.1182/blood.V106.11.5287.5287

Published: 2005

Journal Articles

Thrombotic Microangiopathy™ after Allogeneic Peripheral Blood Stem Cell Transplantation with Nonmyeloablative Conditioning (NMSCT) Compared with Myeloablative Conditioning (MSCT).

Evelyne Willems, MD, Frédéric Baron, MD, PhD, Georges Fillet, MD, PhD, Yves Beguin, MD, PhD

Blood (2005) 106 (11): 1774.

https://doi.org/10.1182/blood.V106.11.1774.1774

Published: 2005

Journal Articles

Infections after Allogeneic Hematopoietic Stem Cell Transplantation with a Nonmyeloablative Conditioning Regimen.

Pascale Frère, MD, Frédéric Baron, MD, Christoffe Bonnet, MD, Kaoutar Hafraoui, MD, Maguy Pereira, RN, Evelyne Willems, MD, Georges Fillet, MD, PhD, Yves Beguin, MD, PhD

Blood (2004) 104 (11): 5086.

https://doi.org/10.1182/blood.V104.11.5086.5086

Published: 2004

NARROW

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

Long-Term Safety Follow-up of a Randomized Trial of Darbepoetin Alpha and Intravenous Iron Following Autologous Hematopoietic Cell Transplantation

Nonmyeloablative Stem Cell Transplantation with CD8-Depleted or Unmanipulated Peripheral Blood Stem Cells: A Prospective Randomized Trial.

Pegfilgrastrim Compared with Filgrastim after Autologous Hematopoietic Peripheral Blood Stem Cell Transplantation.

Thrombotic Microangiopathy™ after Allogeneic Peripheral Blood Stem Cell Transplantation with Nonmyeloablative Conditioning (NMSCT) Compared with Myeloablative Conditioning (MSCT).

Infections after Allogeneic Hematopoietic Stem Cell Transplantation with a Nonmyeloablative Conditioning Regimen.

Email alerts

ASH Publications

American Society of Hematology

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

Long-Term Safety Follow-up of a Randomized Trial of Darbepoetin Alpha and Intravenous Iron Following Autologous Hematopoietic Cell Transplantation

Nonmyeloablative Stem Cell Transplantation with CD8-Depleted or Unmanipulated Peripheral Blood Stem Cells: A Prospective Randomized Trial.

Pegfilgrastrim Compared with Filgrastim after Autologous Hematopoietic Peripheral Blood Stem Cell Transplantation.

Thrombotic Microangiopathy™ after Allogeneic Peripheral Blood Stem Cell Transplantation with Nonmyeloablative Conditioning (NMSCT) Compared with Myeloablative Conditioning (MSCT).

Infections after Allogeneic Hematopoietic Stem Cell Transplantation with a Nonmyeloablative Conditioning Regimen.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only